Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 08/03/22 07:30:40 on US and Canada Markets.
SANTA CLARA, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Applied Materials, Inc. will hold a webcast to discuss its third quarter of fiscal 2022 financial results on Thursday, Aug. 18, 2022 at 4:30 p.m. ET / 1:30 p.m. PT. The live webcast will be accessible via the Applied Materials web...
CINCINNATI, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. ( Nasdaq: HLMN ) (the “Company” or “Hillman”), a leading provider of hardware products and merchandising solutions, reported financial results for the thirteen and twenty-six weeks ende...
CINCINNATI, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “ Company ”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced that it will host its Fiscal Q3 2022 earni...
Reports Q2 Revenues of $1.36 Billion, up 46% on Strength Across All Core Businesses and Addition of HydroChemPSC Generates Q2 Net Income of $148.2 Million, or GAAP EPS of $2.71 and Adjusted EPS of $2.44 Achieves Q2 Adjusted EBITDA Growth of 65% to $309.1 Million ...
Continued Strong Growth in Revenue, Operating Profit, Net Income, Adjusted EBITDA and EPS 2Q Highlights: Revenue up 8%, r eflecting 13% organic growth Operating profit: GAAP up 32% to $97M; non-GAAP up 12% to $124M Operating margin: GAAP 8.5%; non-G...
Conference call and webcast at 8:30am ET Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing differentiated and innovative products across a range of therapies, toda...
– ARCALYST ® (rilonacept) net revenue of $27.0 million in Q2 2022 – – ARCALYST full-year 2022 net revenue expected to be $115 - $130 million – – Upfront and near-term proceeds of $100 million expected from vixareli...
Poseida Therapeutics Announces Strategic Global Collaboration with Roche Focused on Allogeneic CAR-T Cell Therapies for Hematologic Malignancies PR Newswire Leveraging Poseida's novel approach to cell therapy and Roche's expertise in developing and commercializing ther...
MANITOWOC, Wis., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Orion Energy Systems, Inc. (NASDAQ: OESX) ( Orion Lighting ), a provider of energy-efficient LED lighting and control systems and electrical maintenance services, today reported results for its fiscal 2023 first quarter ended Ju...
YAVNE, Israel, Aug. 03, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced that the U.S. Food and Drug Admini...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
8.79%Change Percent:
Autoliv Inc. Company Name:
ALV Stock Symbol:
NYSE Market:
autoliv.com Website: